» Articles » PMID: 24935378

MiR-186 Regulates Glycolysis Through Glut1 During the Formation of Cancer-associated Fibroblasts

Overview
Specialty Oncology
Date 2014 Jun 18
PMID 24935378
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging evidence has suggested that glycolysis is enhanced in cancer-associated fibroblasts (CAF), and miR-186 is downregulated during the CAF formation. However, it is not clear whether miR-186 is involved in the regulation of glycolysis and what the role of miR-186 plays during the CAF formation. In this study, quantitative PCR analysises show miR-186 is downregulated during the CAF formation. Moreover, miR-186 targets the 3' UTR of Glut1, and its overexpression results in the degradation of Glut1 mRNA, which eventually reduces the level of Glut1 protein. On the other hand, knockdown of miR-186 increased the expression of Glut1. Both time course and dose response experiments also demonstrated that the protein and mRNA levels of Glut1 increase during CAF formation, according to Western blot and quantitative PCR analyses, respectively. Most importantly, besides the regulation on cell cycle progression, miR-186 regulates glucose uptake and lactate production which is mediated by Glut1. These observations suggest that miR-186 plays important roles in glycolysis regulation as well as cell cycle checkpoint activation.

Citing Articles

Metabolic Reprogramming of Cancer-Associated Fibroblast in the Tumor Microenvironment: From Basics to Clinic.

Zhou L, Zhang W, Hu X, Wang D, Tang D Clin Med Insights Oncol. 2024; 18:11795549241287058.

PMID: 39450056 PMC: 11500237. DOI: 10.1177/11795549241287058.


Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy.

Ni X, Lu C, Xu G, Ma J Acta Pharmacol Sin. 2024; 45(8):1533-1555.

PMID: 38622288 PMC: 11272797. DOI: 10.1038/s41401-024-01264-1.


Metabolite and protein shifts in mature erythrocyte under hypoxia.

Jin X, Zhang Y, Wang D, Zhang X, Li Y, Wang D iScience. 2024; 27(4):109315.

PMID: 38487547 PMC: 10937114. DOI: 10.1016/j.isci.2024.109315.


Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance.

Mazumder S, Higgins P, Samarakoon R Cancers (Basel). 2023; 15(4).

PMID: 36831657 PMC: 9953937. DOI: 10.3390/cancers15041316.


Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma.

Shao L, Liang L, Fang Q, Wang J Heliyon. 2022; 8(10):e10832.

PMID: 36217480 PMC: 9547242. DOI: 10.1016/j.heliyon.2022.e10832.